Skip to content
10-Q

Quarterly Report

MICROLIN BIO, INC

0001393905-14-000624

← back to feed
Filed
Nov 14, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Sep 30, 2014 9.1M sh
Stockholders Equity Q3 2014 · Sep 30, 2014 −$148.09K
Stockholders Equity Q3 2014 · Dec 31, 2013 $53.58K
Current Liabilities Q3 2014 · Sep 30, 2014 $148.47K
Current Liabilities Q3 2014 · Dec 31, 2013 $47.65K
Total Liabilities Q3 2014 · Sep 30, 2014 $148.47K
Total Liabilities Q3 2014 · Dec 31, 2013 $47.65K
Current Assets Q3 2014 · Sep 30, 2014 $379
Current Assets Q3 2014 · Dec 31, 2013 $101.23K
Total Assets Q3 2014 · Sep 30, 2014 $379
Total Assets Q3 2014 · Dec 31, 2013 $101.23K
Operating Cash Flow restated Q3 2014 · Sep 30, 2013 −$5.87K
Cash And Equivalents Q3 2014 · Sep 30, 2013 $569
Cash And Equivalents Q3 2014 · Dec 31, 2012 $435
Sga Expense restated Q3 2014 · Sep 30, 2013 $3.61K
Sga Expense restated Q3 2014 · Sep 30, 2013 $8.3K
Net Income Q3 2014 · Sep 30, 2013 −$5.32K
Net Income Q3 2014 · Sep 30, 2013 −$10.01K
Stock Issued Q3 2014 · Dec 31, 2012 8.5M sh